Chamber Cardio Closes on $8M Seed Round Led by General Catalyst

George Aloth

Washington, D.C.-based Chamber Cardio said it raised $8 million in a seed round led by General Catalyst, as it builds a plan to partner with cardiology practices in a market worth an estimated $400 billion annually. Existing investor AlleyCorp, and new investors Company Ventures, American Family Ventures and City Light participated.

The company was co-founded by the trio of George Aloth, former president and CEO of a Blue Cross Blue Shield health plan; Dr. Sameer Sheth, a cardiologist; and Dr. Jeffrey De Flavio, a co-founder of Pearl Health and founding CEO of Groups Recover Together. Sheth, a Yale graduate, is a board-certified cardiologist practicing at Mass General Hospital, a Harvard Medical School affiliate.

“Our objective is to provide unparalleled support to cardiologists as they navigate the transition to value-based care, putting them in control of their practice,” said Aloth, a healthcare operations veteran. “By doing so, we aim to provide patients with the highest quality of care, ultimately improving health outcomes for heart disease.”

With cardiovascular care expected to intensify with rising disease and aging populations, said Catalyst managing director Chris Bischoff, “our partnership with Chamber aims to shift cardiology care toward value, enhancing access to high-quality care and lowering healthcare costs.”

Chamber says it aims to fix a lack of technological support that has hobbled cardiologists nationwide, with many expressing frustration at being unable to raise care levels. Other issues with current cardiac care include negotiations with payers. The company says it addresses these issues by equipping cardiologists with real-time insights, evidence-based guidelines, care teams, and contracting support to streamline workflows.

“The multi-trillion dollar shift to outcome-driven reimbursement is accelerating across healthcare, especially in cardiology,” said De Flavio, an expert in value-based care and clinical redesign. “Cardiologists and insurers are seizing this opportunity to improve care and align reimbursement with our industry leading technology.”